Industrial 3D Printing in Pharmaceutical Manufacturing

Synopsis

Homegrown 3D printing was thrust into the global mainstream as a temporary healthcare solution to support efforts to fight COVID-19, but with global supply chains still reeling from the pandemic, there continues to be a focus on building resilient, long-term, production capabilities across the pharmaceutical industry. This presentation takes a unique approach to detailing how the role of the three pillars of industrial 3D printing goes far beyond a stopgap and describes how innovative pharma manufacturers can take advantage of this technology to drastically reduce downtime, improve supply chain security and make significant efficiency gains.